Otsuka Pharmaceutical

  • About Us
  • Nutraceutical
  • Pharmaceutical
    • Central Nervous System
    • Cardiovascular
    • Respiratory System
    • Clinical Nutrition
    • Endocrinology
    • Gastrointestinal
    • Haematology & Oncology
    • Nephrology
  • Contact Us
  • 繁|ENG
What's New

2022.10.11 |
[For Healthcare Professionals only] Safety Information Update on Abilify Tablets and Abilify DISCMELT Orally Disintegrating Tablets
2022.08.31 |
[For Healthcare Professionals only] Safety Information Update on Jinarc Tablets
2022.01.19 |
[Pharmaceutical] Newly Launched Pre-mixed Flavor Formulation (Fruit) for Aminoleban EN® Powder (HK-52479), an Oral Nutritional Supplement for People Concerned about Nutritional Deficiencies and Liver Health
2021.12.07 |
[For Healthcare Professionals only] Safety Information Update on Abilify Maintena Extended Release Injectable Suspension
2021.11.10 |
[For Healthcare Professionals only] Safety Information Update on Iclusig Tablets
2021.11.10 |
[For Healthcare Professionals only] Safety Information Update on Rexulti Tablets
 
Privacy
HKOP-ALL-202202-001 | Copyright© Otsuka Pharmaceutical (H.K.) Ltd.